Does Quetiapine Increase Hunger?
Yes, quetiapine increases hunger and causes significant weight gain through multiple metabolic mechanisms, including increased appetite, though the effect is dose-dependent.
Evidence from Guidelines and FDA Labeling
The 2015 Endocrine Society Clinical Practice Guideline directly addresses quetiapine's metabolic effects. In a randomized trial of five antipsychotic medications, 16% of patients taking quetiapine experienced weight gain of >7% from baseline 1. The guideline explicitly recommends using weight-neutral antipsychotic alternatives when clinically indicated rather than agents like quetiapine that cause weight gain 1.
The FDA drug label for quetiapine confirms these concerns, stating: "Weight gain is common in people who take quetiapine fumarate tablets so you and your healthcare provider should check your weight regularly" 2. The label specifically lists "increased appetite" as a common side effect in children and adolescents 2, with 9% experiencing this adverse effect in clinical trials 2.
Dose-Dependent Effects
The metabolic impact of quetiapine is dose-dependent, but even low doses cause clinically significant problems. A 2017 Gastroenterology guideline notes that quetiapine is "consistently associated with weight gain" 3. Recent research confirms that low-dose quetiapine (<200 mg/day) causes significant weight gain (mean difference 0.58 kg) and patients are 2.12 times more likely to gain ≥7% of baseline weight 4. A prospective cohort study demonstrated that daily dose influences both absolute weight gain and the risk of clinically relevant weight gain (≥7%), with dose-dependent effects on cholesterol and triglycerides 5.
Mechanisms and Clinical Implications
Quetiapine increases hunger through antagonism of histamine H1 receptors in the hypothalamus, anticholinergic effects, and serotonin 5-HT2C antagonism 1. One pediatric study found that risperidone (but not quetiapine) increased appetite during oral glucose tolerance testing, though this doesn't exclude quetiapine's appetite effects in other contexts 6. The antidepressant effects may involve the metabolite norquetiapine's inhibition of noradrenaline reuptake 7.
Comparative Risk Among Antipsychotics
Among atypical antipsychotics, quetiapine carries moderate-to-high weight gain risk. The ranking from highest to lowest weight gain potential is: olanzapine (30% with >7% weight gain) > quetiapine (16%) > risperidone (14%) > perphenazine (12%) > ziprasidone (7%) 1. Lurasidone and ziprasidone are the most weight-neutral alternatives 3.
Clinical Management
When prescribing quetiapine, counsel patients explicitly about appetite increase and weight gain risk before initiation. Monitor weight at every visit, with particular attention to:
- Weight gain >2 kg in one month
- ≥7% increase from baseline body weight 8
Consider metformin (1000 mg daily) or topiramate (100 mg daily) as adjunctive therapy to counteract weight gain (metformin: mean difference -3.27 kg; topiramate: mean difference -3.76 kg) 8.
The 2023 JAMA obesity review emphasizes that when initiating medications, clinicians should select therapies least likely to cause weight gain among options with similar efficacy 8. For patients requiring antipsychotic treatment, consider switching to ziprasidone or lurasidone if metabolic complications develop, as patients lose weight when switched from quetiapine to ziprasidone with improvements in lipid profile and glucose tolerance 3.
Special Populations
In children and adolescents, quetiapine causes particularly concerning metabolic effects. Clinical trials showed 9% of pediatric patients experienced increased appetite, with weight gain of 6% reported 2. The 2001 AACAP guideline notes that weight gain with atypical antipsychotics "may be extreme" in youth 9.
Baseline binge-eating behavior significantly moderates quetiapine's weight effects. Patients with baseline binge-eating on quetiapine experienced the largest increases in body weight, BMI, and waist circumference compared to those without binge-eating or those on lithium 10.